<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00601809</url>
  </required_header>
  <id_info>
    <org_study_id>GUSBOCA</org_study_id>
    <nct_id>NCT00601809</nct_id>
  </id_info>
  <brief_title>(Gastrografin Use in Small Bowel Obstruction Caused by Adherences)</brief_title>
  <acronym>GUSBOCA</acronym>
  <official_title>Gastrografin Use in Small Bowel Obstruction Caused by Adherences</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Bologna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Bologna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adhesive small intestine obstruction (ASIO) is an important cause of hospital admission and a
      very common disease. Any improvement in this field will benefit many patients by reducing the
      operative rate. Patients with this disease are difficult to evaluate and to manage and their
      treatment is controversial. Emergency surgery is mandatory when strangulation is suspected or
      in the case of total obstruction. On the other hand, conservative non-operative treatment is
      indicated in the case of partial obstruction. The role of water-soluble contrast medium
      (Gastrografin®: GG) in ASIO is still debated with regard to the therapeutic value.

      The aim of our study was to determine the therapeutic role of Gastrografin in patients with
      small intestine obstruction without strangulation caused by adherences (ASIO).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2003</start_date>
  <completion_date type="Actual">November 2006</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The operative rate in ASIO patients</measure>
    <time_frame>Within 72 hours and during hospital stay</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The incidence of major and minor complications of treatments in the two arm</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The ASIO recurrences</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The time to resolution of obstruction</measure>
    <time_frame>Within hospital stay</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The length of hospital stay</measure>
    <time_frame>Within hospital admission period</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">76</enrollment>
  <condition>Adhesive Small Intestine Obstruction</condition>
  <arm_group>
    <arm_group_label>GG</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>TT</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>traditional conservative treatment (TT)</intervention_name>
    <description>In the control group (TT: Traditional Treatment), the patients have been treated as in our daily surgical practice of traditional conservative treatment for ASIO, consisting in nil per os diet, nasogastric tube (NGT) decompression and intravenous fluid resuscitation therapy with electrolytes imbalances correction.</description>
    <arm_group_label>TT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gastrografin®: G</intervention_name>
    <description>The study group (GG: Gastrografin Group) received, beyond the traditional conservative treatment for ASIO above mentioned, a G meal with a follow-through study immediately.</description>
    <arm_group_label>GG</arm_group_label>
    <other_name>water-soluble contrast medium (Gastrografin®: G) meal</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients (&gt;18 years)

          -  History of previous abdominal surgical procedures

          -  Clinical and radiological evidence of adhesive small intestine obstruction without
             signs of strangulation and peritonism

          -  ASA I-III patients

          -  Informed consent

        Exclusion Criteria:

          -  Suspicion of strangulation

          -  Actual presence or high suspicion of intra-abdominal malignancy

          -  Suspicion or history of peritoneal carcinomatosis

          -  active inflammatory bowel disease

          -  Positive history of radiotherapy on the abdominal region

          -  Obstructed hernias
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fausto Catena, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>S.Orsola-Malpighi University Hospital - University of Bologna</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Luca Ansaloni, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>S.Orsola-Malpighi University Hospital - University of Bologna</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Margherita Gavioli, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Modena</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Salomone Di Saverio, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>S.Orsola-Malpighi University Hospital - University of Bologna</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>S.Orsola-Malpighi University Hospital - University of Bologna</name>
      <address>
        <city>Bologna</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emergency Surgery Department - University of Modena</name>
      <address>
        <city>Modena</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>January 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 14, 2008</study_first_submitted>
  <study_first_submitted_qc>January 25, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 28, 2008</study_first_posted>
  <last_update_submitted>January 25, 2008</last_update_submitted>
  <last_update_submitted_qc>January 25, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 28, 2008</last_update_posted>
  <responsible_party>
    <name_title>Dr. Fausto Catena M.D. PhD</name_title>
    <organization>S. Orsola Malpighi University Hospital - University of Bologna</organization>
  </responsible_party>
  <keyword>Gastrointestinal</keyword>
  <keyword>Adhesive Small Intestine Obstruction</keyword>
  <keyword>Oral water soluble contrast</keyword>
  <keyword>Non-operative Conservative Management</keyword>
  <keyword>Operative rate</keyword>
  <keyword>Hospital stay</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intestinal Obstruction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

